Indications for trans-scleral local resection of uveal melanoma ED1TOR,-In his recent editorial,' Shields criticises us for not including our indications and contraindications for local resection of uveal melanoma. Our indications and contraindications are, indeed, different from his and we thought it would be useful to itemise them as follows:
(1) A large tumour thickness and secondary retinal detachment complicate radiotherapy but facilitate local resection. Ruthenium plaque radiotherapy is contraindicated for tumours more than 5 mm thick and, with larger tumours, iodine plaque radiotherapy and charged particle radiotherapy have a high complication rate." Our main indication for local resection, therefore, is a tumour size deemed excessive for radiotherapy.
(2) A tumour is not inoperable just because it has a large basal diameter (> 15 mm). Statistical studies show that large diameter is not an independent risk factor for visual loss.4 There is an increased risk of local tumour recurrence, however, so that special precautions, such as wide clearance margins and adjunctive treatment, are necessary.5 Although there is an increased probability of metastatic disease,6 this is no worse than after enucleation.7 (3) Tumour extension to within one disc diameter of the optic disc is not a contraindication. Although the risks of local tumour recurrence,5 and retinal detachment are increased, both of these complications are usually preventable and treatable, unlike radiational optic neuropathy, which causes severe visual loss and neovascular complications.
(4) Tumour proximity to the fovea is not a contraindication, because although central visual loss may be inevitable, this is also the case with any other form of treatment. Preservation of the temporal field of vision is worthwhile even if central vision is good in the fellow eye. For many patients, preservation of both eyes is important not only for self esteem, but also for social and occupational reasons.
(5) Retinal invasion is not a contraindication, because it is usually possible to preserve an intact retina, prevent retinal detachment by external plombage and photocoagulation, and prevent local tumour recurrence by photocoagulation and plaque radiotherapy. Retinal perforation by tumour causes problems not only with local excision but also after radiotherapy, and if there is vitreous seeding enucleation is the safest option.
(6) Extraocular extension, if small, is not a contraindication, because it can be excised en bloc, with the full thickness scleral defect closed using a lamellar graft from another part of the same eye.
(7) Old age is not in itself a contraindication to local resection despite the use of hypotensive anaesthesia for controlling haemorrhage. If anything, old age facilitates haemostasis because during hypotensive anaesthesia bleeding stops at a higher pressure than is the case in younger patients. We have operated on patients older than 75 years of age without incurring systemic complications and, statistically, old age is not a risk factor for visual loss.4 (8) Diffuse melanomas are very aggressive, and best treated by enucleation.
(9) Involvement of more than a third of ciliary body or angle creates difficulties not only for local resection but also radiotherapy, and is an indication for enucleation unless the patient is extremely reluctant to lose the eye, when some form of combination treatment may be attempted.
(10) Optic disc involvement is usually a contraindication, although in some cases it is possible to peel the tumour away from the disc and treat the area by photocoagulation.
(11) Systemic contraindications to systemic hypotensive anaesthesia vary from anaesthetist to anaesthetist, and include any significant circulatory, cardiac, pulmonary, hepatic, or renal insufficiency. Diabetes mellitus is not a contraindication.
(12) As with any surgical procedure, local resection (which includes vitrectomy as an integral part of the procedure) should be performed only by surgeons who have a sufficient competence in the technique and the ability to deal with recurrent tumour. Incomplete excision and local tumour recurrence are not associated with an increased incidence of metastatic disease6; however, adjunctive plaque radiotherapy seems to improve the chances of survival6 so that it is now difficult to justify local resection without additional treatment.
Unlike Shields, we do not consider local resection to be 'a time consuming procedure which requires more complicated postoperative care'. The procedure is usually completed within 3 hours, depending on the size of the scleral flap, and this is comparable with many vitreoretinal procedures. Patients return to a general ophthalmic ward after about 2 hours in a recovery suite. They are mobile on the first postoperative day and are allowed home on the third postoperative day. Subsequent follow up is the same as for any other form of conservative therapy for uveal melanoma. I find that our differences are minor but they do warrant further comment, based on our personal experience.'
(1) My colleagues and I agree that tumours with greater tumour thickness and secondary retinal detachment can be successfully resected and that retinal detachment may actually facilitate the procedure. However, we do not agree that thicker tumours in the peripheral choroid and ciliary body have such a high complication rate following plaque radiotherapy. The main complication is cataract but the ophthalmologist can remove a cataract with restoration of vision, provided that there is no significant posterior radiation retinopathy. Cataract is certainly a common problem after local resection as well. We have treated with plaques many patients with ciliary body tumours greater than 3 clock hours with satisfactory results and we are generally happy that we did not attempt to resect the tumours. After plaque radiotherapy for peripheral melanomas, the visual acuity usually remains In short, the entire volume is simply magnificent.
The organisation of the atlas is good in two respects. Different phases of a single case history are presented as a group showing early, late, and treated stages; and, secondly, important clinical differential diagnoses are juxtaposed: lymphoma ofthe lacrimal gland against pleomorphic adenoma, and astrocytic hamartoma of the retina against retinoblastoma, for example, and a whole panel of photographs illustrates and compares different neurodegenerative diseases of the retina. This is a very helpful feature throughout the book, and if that means there is occasional duplication of material, so be it.
The other main theme in this atlas is the depiction of pathology and clinical material side by side. Indeed, it constitutes a superb clinicopathological conference. The spectrum of histopathology, gross specimens, scanning and transmission electron microscopy, microbiology, immunohistochemistry, cytology, and radioimaging which is used to illuminate the clinical material here is amazing and entirely
